Skip to main content
Screener/Healthcare/Biotechnology

ORKA — Oruka Therapeutics, Inc.

NASDAQ
$102.32+6.41 (+6.68%)
Mid CapHealthcareHigh DividendDividend Stock
$25.23
$115.52
$96.05
$102.95
EPS (TTM)$-2.39
P/E Ratio-38.19
Dividend Yield17.93%
Market Cap$6.41B
Volume755K
Prev Close$96.02
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$31.8M$-0.58——
Q4 '25$0-$29.6M$-0.54——
Q3 '25$0-$30.3M$-0.69——
Q2 '25$0-$24.6M$-0.58——
Q1 '25$0-$21.0M$-0.50——
Q4 '24$0-$33.4M$-1.54——
Q3 '24$0-$28.6M$-1.91——
Q2 '24$0-$22.2M$-1.30——
Get Your Daily Market Recap